Activation of STAT3 and upstream cytokines such as IL-6 promotes tumor cell survival, stromal remodeling, and resistance to 5-fluorouracil (5-FU) and oxaliplatin through modulation of EMT, DNA repair pathways, and anti-apoptotic programs [19,21,26,30]. The gene discussed is STAT3; the disease is neoplasm.